{
    "nctId": "NCT04176809",
    "briefTitle": "Health-Related Quality of Life Coupled With Therapeutic Information on Compliance to Endocrine Therapy in Breast Cancer",
    "officialTitle": "Impact of Routine Assessment of Health-Related Quality of Life Coupled With Therapeutic Information on Compliance With Endocrine Therapy in Patients With Non-metastatic Breast Cancer",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "OTHER",
    "enrollmentCount": 342,
    "primaryOutcomeMeasure": "Number of participants compliant with endocrine therapy as assessed by Morisky Green Levine (MGL) scale",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Women aged 18 and over\n* With non-metastatic hormone receptor positive breast cancer\n* Women will have to be at the end of primary treatment\n* An indication for endocrine therapy treatment during 5 to 10 years\n* be affiliated to a French social security scheme or beneficiary of such a scheme\n* agreed to participate by signing a written consent\n\nExclusion Criteria:\n\n* Participants who participate in another clinical trial where HRQoL is assessed\n* Women for whom HRQoL evaluation is not possible (cognitive disorders, psychiatric disorders, people who do not speak French, etc.).\n* Vulnerable participants (pregnant women, etc.)",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}